Membranous nephropathy: Quo vadis?

被引:25
作者
Cattran, DC [1 ]
机构
[1] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 1L7, Canada
关键词
glomerulonephritis; end-stage renal disease; proteinuria; creatinine levels;
D O I
10.1046/j.1523-1755.2002.00125.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:349 / 350
页数:2
相关论文
共 13 条
  • [1] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner, BM
    Cooper, ME
    de Zeeuw, D
    Keane, WF
    Mitch, WE
    Parving, HH
    Remuzzi, G
    Snapinn, SM
    Zhang, ZX
    Shahinfar, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869
  • [2] A CONTROLLED TRIAL OF CYCLOSPORINE IN PATIENTS WITH PROGRESSIVE MEMBRANOUS NEPHROPATHY
    CATTRAN, DC
    GREENWOOD, C
    RITCHIE, S
    BERNSTEIN, K
    CHURCHILL, DN
    CLARK, WF
    MORRIN, PA
    LAVOIE, S
    [J]. KIDNEY INTERNATIONAL, 1995, 47 (04) : 1130 - 1135
  • [3] Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications
    Cattran, DC
    Pei, Y
    Greenwood, CMT
    Ponticelli, C
    Passerini, P
    Honkanen, E
    [J]. KIDNEY INTERNATIONAL, 1997, 51 (03) : 901 - 907
  • [4] A RANDOMIZED CONTROLLED TRIAL OF PREDNISONE IN PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY
    CATTRAN, DC
    DELMORE, T
    ROSCOE, J
    COLE, E
    CARDELLA, C
    CHARRON, R
    RITCHIE, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (04) : 210 - 215
  • [5] COGGINS CH, 1979, NEW ENGL J MED, V301, P1301
  • [6] TREATMENT OF PROGRESSIVE MEMBRANOUS GLOMERULOPATHY - A RANDOMIZED TRIAL COMPARING CYCLOPHOSPHAMIDE AND CORTICOSTEROIDS WITH CORTICOSTEROIDS ALONE
    FALK, RJ
    HOGAN, SL
    MULLER, KE
    JENNETTE, JC
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 116 (06) : 438 - 445
  • [7] Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997
    Haas, M
    Meehan, SM
    Karrison, TG
    Spargo, BH
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (05) : 621 - 631
  • [8] Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
    Lewis, EJ
    Hunsicker, LG
    Clarke, WR
    Berl, T
    Pohl, MA
    Lewis, JB
    Ritz, E
    Atkins, RC
    Rohde, R
    Raz, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 851 - 860
  • [9] *NIH NAT I DIAB DI, 1999, US REN DAT SYST USRD
  • [10] PREDICTING CHRONIC RENAL-INSUFFICIENCY IN IDIOPATHIC MEMBRANOUS GLOMERULONEPHRITIS
    PEI, Y
    CATTRAN, D
    GREENWOOD, C
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (04) : 960 - 966